Journal article · 2012 · Open access
The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study
Indian Journal of Nephrology, 22(4), 285 · Published 1 July 2012 · DOI 10.4103/0971-4065.101249
In brief
“The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study” is a 2012 journal article by B Ghosh and 6 co-authors, published in Indian Journal of Nephrology. OpenAlex counts 45 citations as of 22 November 2026, which puts it in the top 8% of works published in 2012 by citations. It is open access: the full text is free to read at Indian Journal of Nephrology.
- Citations
- 45
- Most cited in
- 2020 (6)
- Field-weighted impact
- 1.60
- References
- 38
- Authors
- 7
Abstract
Mineral bone disorder (MBD) is an important complication of chronic kidney disease (CKD). However, there are limited data on the pattern of MBD in Indian CKD population. The aim of this study was to describe spectrum of MBD in patients with CKD in our center. This was a hospital-based cross-sectional observational study. Patients with stage 4 and 5 CKD were included in this study. Those receiving calcium supplement, vitamin D or its analogues, and calcimimetic were excluded. Serum/plasma levels of creatinine, albumin, calcium, phosphate, total alkaline phosphatase (TAP), intact parathormone (iPTH), and 25-OH vitaminD (25-vitD) were measured. Radiological survey of bones was carried out in all cases, and echocardiography done in selected patients. Statistical analysis was done using Sigmaplot 10.0 software. A total of 150 patients (114 males, 36 females) were included in this study. Mean age was 45.67±16.96 years. CKD stage 4 and 5D were found in 26% (n=39) and 74% (n=111) of study population, respectively. The most common underlying native kidney diseases in patients of CKD 4 and 5D were diabetic nephropathy (41.03%) and CGN (41.44%), respectively. Median (first quartile, third quartile) values for serum levels of corrected calcium (cCa), phosphate, cCaXPO4 product, TAP, plasma iPTH, and 25-vitD in stage 4 CKD were 8.36 (7.79, 8.91) mg/dL, 4.9 (3.92, 6.4) mg/dL, 41.11 (34.01, 53.81) mg(2)/dL(2), 97 (76.5, 184.25) IU/L, 231 (124.5, 430.75) pg/mL, and 12 (6.98, 23.55) ng/mL, respectively; and in stage 5D CKD were 8.36 (7.66, 8.95) mg/dL, 5.7 (4.23, 6.95) mg/dL, 46.5 (37.16, 54.47) mg(2)/dL(2), 180 (114.5, 276.25) IU/L, 288 (169.75, 625.0) pg/mL, and 18.4 (10.0, 26.4) ng/mL, respectively. Prevalence of hypocalcemia (56.41% vs. 54.95%), hyperphosphatemia (64.10% vs. 70.27%), and hyperparathyroidism (84.62% vs. 88.29%) was not different between patients with CKD 4 and 5D. However, iPTH level outside the target range and increased TAP level were significantly (P<0.001) more common in CKD stage 5D. Multiple logistic regression analysis for hyperparathyroidism revealed significant inverse correlation with cCa in CKD 5D. There were no significant differences in vitamin D status and prevalence of valvular calcification between CKD stage 4 and 5D. X-ray revealed renal osteodystrophy in 8 (5.33%) patients, while it was normal in 118 (78.67%) patients. Secondary hyperparathyroidism, hyperphosphatemia, hypocalcemia, increased TAP, and 25-OH vitamin D deficiency and insufficiency were quite common in CKD 4 and 5 patients. The commonest type of MBD in CKD 4 and 5D was secondary hyperparathyroidism.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ghosh, B., Singh, T. B., Banerjee, S., Singh, N., Singh, S. K., Sharma, O., & Prakash, J. (2012). The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study. Indian Journal of Nephrology, 22(4), 285. https://doi.org/10.4103/0971-4065.101249
MLA 9
Ghosh, B, et al. “The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study.” Indian Journal of Nephrology, vol. 22, no. 4, 2012, p. 285. https://doi.org/10.4103/0971-4065.101249.
Chicago
Ghosh, B, Takhellambam Brojen Singh, S Banerjee, Nidhi Singh, Shivendra Kumar Singh, OP Sharma, and Jai Prakash. 2012. “The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study.” Indian Journal of Nephrology 22 (4): 285. https://doi.org/10.4103/0971-4065.101249.
Harvard
Ghosh, B. et al. (2012) ‘The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study’, Indian Journal of Nephrology, 22(4), p. 285. doi:10.4103/0971-4065.101249.
IEEE
B. Ghosh et al., “The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study,” Indian Journal of Nephrology, vol. 22, no. 4, p. 285, 2012, doi: 10.4103/0971-4065.101249.
BibTeX
@article{ghosh2012high,
title = {{The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study}},
author = {Ghosh, B and Singh, Takhellambam Brojen and Banerjee, S and Singh, Nidhi and Singh, Shivendra Kumar and Sharma, OP and Prakash, Jai},
journal = {Indian Journal of Nephrology},
year = {2012},
volume = {22},
number = {4},
pages = {285},
doi = {10.4103/0971-4065.101249},
url = {https://doi.org/10.4103/0971-4065.101249}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 3 | |
| 2018 | 2 | |
| 2019 | 5 | |
| 2020 | 6 | |
| 2021 | 2 | |
| 2022 | 2 | |
| 2023 | 3 | |
| 2024 | 3 | |
| 2025 | 4 | |
| 2026 | 4 |
Its field-weighted citation impact is 1.60: it has been cited 1.60 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- chronic kidney disease
- mineral and bone disorder
- secondary hyperparathyroidism
- intact parathyroid hormone
- phosphate
- calcium
- vitamin D
- diabetic nephropathy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Ghosh, B., Singh, T. B., Banerjee, S., Singh, N., Singh, S. K., Sharma, O., & Prakash, J. (2012). The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study. Indian Journal of Nephrology, 22(4), 285. https://doi.org/10.4103/0971-4065.101249
How many times has this paper been cited?
45 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Indian Journal of Nephrology: sign in and open the full text from this page.
Who wrote this paper?
B Ghosh, Takhellambam Brojen Singh, S Banerjee, Nidhi Singh, Shivendra Kumar Singh, OP Sharma, Jai Prakash.
What is the DOI of this paper?
10.4103/0971-4065.101249, permanently at https://doi.org/10.4103/0971-4065.101249. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.